Prostate cancer, liver cancer, and breast cancer had the highest levels of FASN expression, whereas kidney renal clear cell carcinoma (KIRC) and kidney chromophobe (KICH) exhibited the lowest levels of FASN expression, which is similar to the expression profile of FASN in normal tissues (Figure 1B). The gene discussed is FASN; the disease is prostate carcinoma.